Inspire Medical Systems, Inc.

NYSE INSP

Inspire Medical Systems, Inc. Price to Book Ratio (P/B) on January 14, 2025: 8.16

Inspire Medical Systems, Inc. Price to Book Ratio (P/B) is 8.16 on January 14, 2025, a -20.59% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.

Inspire Medical Systems, Inc. 52-week high Price to Book Ratio (P/B) is 13.35 on May 02, 2024, which is 63.56% above the current Price to Book Ratio (P/B).
Inspire Medical Systems, Inc. 52-week low Price to Book Ratio (P/B) is 6.38 on July 26, 2024, which is -21.89% below the current Price to Book Ratio (P/B).
Inspire Medical Systems, Inc. average Price to Book Ratio (P/B) for the last 52 weeks is 9.73.

Key data

Date	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield	Price to Earnings Ratio (P/E)

NYSE: INSP

Inspire Medical Systems, Inc.

CEO	Mr. Timothy P. Herbert
IPO Date	May 3, 2018
Location	United States
Headquarters	5500 Wayzata Boulevard
Employees	1,011
Sector	Health Care
Industries Telehealth Pharmaceuticals

Description

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Key trends

Past 5 years